Your browser is no longer supported. Please, upgrade your browser.
Settings
PBYI Puma Biotechnology, Inc. daily Stock Chart
PBYI [NASD]
Puma Biotechnology, Inc.
Index- P/E- EPS (ttm)-3.90 Insider Own11.10% Shs Outstand38.60M Perf Week5.13%
Market Cap1.07B Forward P/E- EPS next Y-1.97 Insider Trans-0.52% Shs Float32.99M Perf Month9.24%
Income-147.00M PEG- EPS next Q-0.77 Inst Own95.00% Short Float13.62% Perf Quarter25.43%
Sales201.50M P/S5.30 EPS this Y5.20% Inst Trans-0.85% Short Ratio4.81 Perf Half Y-34.82%
Book/sh1.21 P/B22.87 EPS next Y33.70% ROA-74.10% Target Price38.89 Perf Year-59.55%
Cash/sh3.32 P/C8.34 EPS next 5Y- ROE-301.50% 52W Range17.60 - 83.15 Perf YTD35.97%
Dividend- P/FCF- EPS past 5Y-18.10% ROI-287.20% 52W High-66.72% Beta0.66
Dividend %- Quick Ratio3.00 Sales past 5Y- Gross Margin86.00% 52W Low57.22% ATR1.16
Employees318 Current Ratio3.00 Sales Q/Q926.20% Oper. Margin-69.30% RSI (14)61.18 Volatility3.20% 4.29%
OptionableYes Debt/Eq2.64 EPS Q/Q82.00% Profit Margin-72.90% Rel Volume0.70 Prev Close27.13
ShortableYes LT Debt/Eq2.64 EarningsFeb 28 AMC Payout- Avg Volume935.06K Price27.67
Recom3.00 SMA204.03% SMA5014.09% SMA200-31.42% Volume658,883 Change1.99%
Jan-17-19Initiated Leerink Partners Mkt Perform $21
Jan-03-19Downgrade Guggenheim Buy → Neutral
Nov-19-18Upgrade Goldman Sell → Neutral
Nov-02-18Downgrade JP Morgan Neutral → Underweight
Nov-02-18Downgrade BofA/Merrill Buy → Underperform
Oct-01-18Initiated Cantor Fitzgerald Overweight $75
Sep-17-18Initiated Goldman Sell $42
May-11-18Reiterated Stifel Buy $95 → $87
Nov-10-17Reiterated RBC Capital Mkts Sector Perform $92 → $108
Nov-10-17Reiterated Citigroup Buy $156 → $164
Oct-02-17Reiterated Stifel Buy $110 → $130
Sep-11-17Reiterated Credit Suisse Outperform $118 → $136
Jul-10-17Resumed Leerink Partners Outperform $115
Jun-06-17Reiterated RBC Capital Mkts Sector Perform $60 → $88
May-25-17Reiterated RBC Capital Mkts Sector Perform $40 → $60
Mar-02-17Reiterated RBC Capital Mkts Sector Perform $48 → $17
Sep-22-16Reiterated Credit Suisse Outperform $54 → $111
Sep-21-16Upgrade Stifel Hold → Buy $61 → $88
Mar-29-16Downgrade RBC Capital Mkts Outperform → Sector Perform $103 → $36
Jan-21-16Initiated Credit Suisse Outperform
Feb-15-19 04:20PM  Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Feb-14-19 12:58PM  5 Drug/Biotech Stocks Set to Beat Estimates in Q4 Earnings Zacks
Feb-13-19 04:20PM  Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results Business Wire
Feb-06-19 12:47PM  Need To Know: Puma Biotechnology, Inc. (NASDAQ:PBYI) Insiders Have Been Selling Shares Simply Wall St.
Feb-04-19 09:54PM  Puma Biotechnology Announces Litigation Victory with Jurys Decision Business Wire
Jan-22-19 11:02AM  Is Puma Biotechnology a Buy? Motley Fool -6.11%
Jan-17-19 07:45AM  Detailed Research: Economic Perspectives on Delta Air Lines, Duke Energy, Fiserv, The Chefs' Warehouse, Maxim Integrated Products, and Puma Biotechnology What Drives Growth in Today's Competitive Landscape GlobeNewswire
Jan-11-19 10:38AM  Puma Biotech (PBYI) Down More Than 40% in 90 Days: Here's Why Zacks -6.44%
08:03AM  Puma Biotechnology and Knight Therapeutics Enter into Exclusive License Agreement to Commercialize NERLYNX® (neratinib) in Canada Business Wire
08:00AM  Knight Therapeutics Runs with Exclusive Canadian License to Pumas NERLYNX® GlobeNewswire
Jan-10-19 03:19PM  Athenex Completes Enrollment Target for Breast Cancer Study Zacks +5.35%
Jan-03-19 04:20PM  Puma Biotechnology to Present at J. P. Morgan Healthcare Conference Business Wire
Jan-02-19 04:50PM  Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Business Wire +6.54%
Dec-18-18 11:10AM  A Bull And Bear Review Positive Results For Puma Biotech's Late-Stage Breast Cancer Drug Trial Benzinga
10:20AM  Puma Biotech's Nerlynx Ups Survival in Third-Line Breast Cancer Zacks
08:00AM  The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan Benzinga
07:00AM  Today's Research Reports on Trending Tickers: Puma Biotechnology and FibroGen ACCESSWIRE
Dec-17-18 04:31PM  Puma Bio stock rises more than 9% on drug study MarketWatch -5.14%
04:05PM  Puma Biotechnology Announces Top Line Results of the Phase III NALA Trial of Neratinib in Patients with HER2-Positive Metastatic Breast Cancer Business Wire
Dec-14-18 03:17AM  Puma Biotechnology Inc (PBYI): Hedge Fund Sentiment Unchanged Insider Monkey
Dec-12-18 08:19AM  3 Beaten-Down Biotech Stocks That Could Bounce Back in 2019 Motley Fool
08:10AM  Investor Expectations to Drive Momentum within CatchMark Timber Trust, Edison International, Puma Biotechnology, Maxim Integrated Products, Wabash National, and Resolute Energy Discovering Underlying Factors of Influence GlobeNewswire
Dec-11-18 05:56PM  Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Dec-10-18 04:35PM  Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Dec-06-18 05:14PM  Here's Why Puma Biotechnology Tanked 37.3% in November Motley Fool
08:00AM  Puma Biotechnology Presents Results of Patient Reported Outcomes in Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2018 San Antonio Breast Cancer Symposium Business Wire
08:00AM  Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of Neratinib for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2018 San Antonio Breast Cancer Symposium Business Wire
08:00AM  Puma Biotechnology Presents Results from the Hormone Receptor Positive Subgroup in Phase III ExteNET Trial of Neratinib for HER2-Amplified, Early Stage Breast Cancer at the 2018 San Antonio Breast Cancer Symposium Business Wire
Dec-03-18 04:20PM  Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Nov-16-18 07:47AM  Edited Transcript of PBYI earnings conference call or presentation 1-Nov-18 8:30pm GMT Thomson Reuters StreetEvents
Nov-09-18 08:20AM  Investor Expectations to Drive Momentum within Matson, Craft Brew Alliance, Easterly Government Properties, Novanta, Ascena Retail Group, and Puma Biotechnology Discovering Underlying Factors of Influence GlobeNewswire
Nov-07-18 04:15PM  Puma Biotechnology to Present at Credit Suisse Healthcare Conference Business Wire
09:30AM  Biotech Stocks and the Midterm Elections ACCESSWIRE
Nov-05-18 10:25AM  Puma Biotech (PBYI) Q3 Loss Narrows, Nerlynx Pulls Stock Down Zacks +13.90%
Nov-02-18 01:47PM  Here's Why Puma Biotechnology Inc. Is Getting Hammered Today Motley Fool -48.01%
08:52AM  Puma Biotechnology's stock plunges to pace premarket losers after key drug Nerlynx disappoints MarketWatch
Nov-01-18 08:45PM  Puma Biotech (PBYI) Reports Q3 Loss, Tops Revenue Estimates Zacks
07:42PM  Puma Biotech: 3Q Earnings Snapshot Associated Press
05:56PM  Why Puma Biotechnology, Inc. Stock Is Getting Crushed Today Motley Fool
04:10PM  Puma Biotechnology Reports Third Quarter 2018 Financial Results Business Wire
Oct-25-18 10:34AM  Puma Biotech (PBYI) Q3 Earnings Preview: What to Look Out For Zacks
Oct-18-18 04:15PM  Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results Business Wire
11:37AM  Puma Biotech (PBYI) Rides High on Robust Nerlynx Performance Zacks
Oct-17-18 07:20AM  Investor Expectations to Drive Momentum within Arsanis, Dynavax Technologies, Puma Biotechnology, Opko Health, Adaptimmune Therapeutics, and Codexis Discovering Underlying Factors of Influence GlobeNewswire
Oct-16-18 05:51PM  Celcuity Announces Clinical Trial Collaboration with Puma Biotechnology and West Cancer Center Business Wire
Oct-10-18 05:00PM  Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Oct-03-18 08:21AM  3 Top Mid-Cap Stocks to Buy in October Motley Fool
Oct-02-18 08:30AM  Puma Biotechnologys Licensing Partner CANbridge Pharmaceutical Submits New Drug Application for NERLYNX® (neratinib) in China Business Wire
Sep-20-18 04:15PM  Puma Biotechnology to Present at Cantor Global Healthcare Conference Business Wire
Sep-06-18 04:20PM  Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Business Wire
11:09AM  Puma Biotech Gets EU Nod for Breast Cancer Drug Nerlynx Zacks
08:52AM  The Zacks Analyst Blog Highlights: Amgen, Puma Biotechnology, MannKind, United Therapeutics and Vertex Pharmaceuticals Zacks
Sep-05-18 04:17PM  Edited Transcript of PBYI earnings conference call or presentation 9-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
09:39AM  Biotech Stock Roundup: AMGN, PBYI Get EC Nod for Their Drugs, MNKD Soars Zacks
Aug-23-18 10:03AM  Factors of Influence in 2018, Key Indicators and Opportunity within Patterson-UTI Energy, Puma Biotechnology, Echelon, McEwen Mining, New Gold, and Qudian Inc. Sponsored ADR New Research Emphasizes Economic Growth GlobeNewswire
Aug-10-18 10:45AM  Puma Biotech (PBYI) Q2 Loss Narrows, Nerlynx Drives Sales Zacks -8.12%
08:00AM  Today's Research Reports on Trending Tickers: Puma Biotechnology and Corcept Therapeutics ACCESSWIRE
Aug-09-18 06:00PM  Puma Biotech (PBYI) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:57PM  Puma Biotech: 2Q Earnings Snapshot Associated Press
04:47PM  Puma Bio shares jump 19% on narrower quarterly loss, bigger sales MarketWatch
04:05PM  Puma Biotechnology Reports Second Quarter 2018 Financial Results Business Wire
Aug-07-18 11:13AM  What's in the Cards for Puma Biotech (PBYI) in Q2 Earnings? Zacks
Jul-31-18 08:30AM  Puma Biotechnology Files New Drug Submission for NERLYNX® in Canada Business Wire
Jul-30-18 07:00AM  Stock Performance Review on Amicus Therapeutics and Three Other Biotech Stocks ACCESSWIRE
Jul-26-18 04:15PM  Puma Biotechnology to Host Conference Call to Discuss Second Quarter Financial Results Business Wire
Jul-17-18 04:15PM  Puma Biotechnology and Strata Oncology Announce Collaboration to Accelerate Enrollment in Neratinib HER2 Mutation Basket Study (SUMMIT Trial) Business Wire
Jul-13-18 01:30PM  Here's Why Puma Biotechnology Rose 11.7% in June Motley Fool
Jun-29-18 07:30AM  Puma Biotechnology Receives Positive CHMP Opinion Recommending Approval of NERLYNX® for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer Business Wire
Jun-28-18 07:35AM  Complimentary Technical Snapshots on Puma Biotech and Three More Biotech Stocks ACCESSWIRE
Jun-27-18 10:32AM  Puma Biotechnology's Shares Rise on Positive CHMP Trend Vote Zacks -10.62%
08:12AM  Biotech Stock Roundup: PBYI Soars, MACK Crashes, GILD's Biktarvy Gets EC Nod Zacks
08:00AM  Todays Research Reports on Stocks to Watch: Puma Biotechnology and Achieve Life Sciences ACCESSWIRE
Jun-26-18 04:31PM  Why Puma Biotechnology Stock Soared Today Motley Fool +24.36%
04:29PM  Why General Electric, Puma Biotechnology, and Lennar Jumped Today Motley Fool
09:28AM  Puma Biotech says Europe likely to approve breast cancer drug Reuters
08:51AM  Puma Biotechnology Announces Results of CHMP Reexamination of MAA for Neratinib for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer Business Wire
Jun-20-18 04:28PM  Former Puma Biotech executive gets U.S. prison term for insider trading Reuters
Jun-18-18 08:30AM  Champions Oncology Partners with Puma Biotechnology and NSABP Foundation on Metastatic Breast and Colon Cancer Co-clinical PDX Studies PR Newswire
Jun-15-18 08:20AM  Today's Research Reports on Trending Tickers: Puma Biotechnology and bluebird bio ACCESSWIRE
Jun-12-18 07:50AM  Detailed Research: Economic Perspectives on Amphenol, Hologic, Newell Brands, Ciena, SAExploration, and Puma Biotechnology What Drives Growth in Today's Competitive Landscape GlobeNewswire
Jun-02-18 09:00AM  Puma Biotechnology Presents Interim Results of Phase Ib/II FB-10 Trial of PB272 in Combination with Trastuzumab Emtansine (T-DM1) in HER2-Positive Metastatic Breast Cancer at the 2018 ASCO Annual Meeting Business Wire
May-30-18 04:05PM  Puma Biotechnology to Present at Jefferies Global Healthcare Conference Business Wire
May-17-18 10:02PM  Edited Transcript of PBYI earnings conference call or presentation 9-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-16-18 08:20AM  Today's Research Reports on Trending Tickers: Puma Biotechnology and Amicus Therapeutics ACCESSWIRE
May-11-18 08:10AM  Todays Research Reports on Stocks to Watch: Puma Biotechnology and Neovasc ACCESSWIRE
May-10-18 01:06PM  Here's Why Puma Biotechnology Inc. Is Sinking Today Motley Fool -20.67%
May-09-18 05:49PM  Puma Biotech: 1Q Earnings Snapshot Associated Press
04:05PM  Puma Biotechnology Reports First Quarter 2018 Financial Results Business Wire
May-08-18 04:15PM  Puma Biotechnology to Present at Bank of America Merrill Lynch Health Care Conference 2018 Business Wire
May-07-18 08:42AM  Puma Biotech (PBYI) to Report Q1 Earnings: What to Expect? Zacks
Apr-30-18 08:20AM  Today's Research Reports on Trending Tickers: Neovasc and Puma Biotechnology ACCESSWIRE -6.59%
Apr-25-18 04:15PM  Puma Biotechnology to Host Conference Call to Discuss First Quarter Financial Results Business Wire
Apr-03-18 08:45AM  Puma Biotechnology and Pint Pharma Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Latin America Business Wire
Apr-02-18 11:19AM  Puma's Shares Fall This Year Post a Solid 2017: Here's Why Zacks -5.36%
08:45AM  NCCN Guidelines for Central Nervous System Cancers Include NERLYNX® (neratinib) in Combination With Capecitabine or Paclitaxel as Treatment Options for Patients With Breast Cancer Brain Metastases Business Wire
04:38AM  Puma Biotechnology (PBYI) Up 10.2% Since Earnings Report: Can It Continue? Zacks
Mar-29-18 11:51AM  Puma Biotechnology Inc (NASDAQ:PBYI) Is Trading At A 47% Discount Simply Wall St.
Mar-28-18 11:00AM  Robbins Geller Rudman & Dowd LLP Announces Pending Class Action in the Puma Biotechnology, Inc. Litigation Business Wire
Mar-09-18 08:42AM  Does Puma Biotechnology Incs (NASDAQ:PBYI) -5.79% Earnings Drop Reflect A Longer Term Trend? Simply Wall St.
Mar-06-18 04:15PM  Puma Biotechnology to Present at Cowens Annual Healthcare Conference Business Wire
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States. Its drug candidates include PB272 neratinib (oral) for the treatment of early stage breast cancer, metastatic breast cancer, non-small cell lung cancer, HER2 mutation-positive solid tumors, and HER2-mutated non-amplified breast cancer; and PB272 neratinib (intravenous)). The company also develops PB357, an orally administered agent that is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. It has a license agreement with Pfizer, Inc. for the development, manufacture, and commercialization of PB272 neratinib (oral), PB272 neratinib (intravenous), PB357, and certain related compounds. Puma Biotechnology, Inc. was founded in 2010 and is headquartered in Los Angeles, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AUERBACH ALAN HPRESIDENT AND CEOFeb 04Sale27.803459,5914,165,467Feb 06 04:30 PM
EYLER CHARLES RSEE REMARKSFeb 04Sale27.64872,40531,957Feb 06 04:38 PM
BRYCE RICHARD PAULSEE REMARKSFeb 04Sale27.77892,47229,285Feb 06 04:34 PM
AUERBACH ALAN HPRESIDENT AND CEOJan 22Sale24.748,825218,3344,165,812Jan 24 04:44 PM
BRYCE RICHARD PAULSEE REMARKSJan 22Sale24.721,95948,42629,374Jan 24 04:47 PM
Lo StevenChief Commercial OfficerJan 22Sale24.912,11452,66421,409Jan 24 04:54 PM
EYLER CHARLES RSEE REMARKSJan 22Sale24.8071317,68232,044Jan 24 04:51 PM
AUERBACH ALAN HPRESIDENT AND CEOJan 03Sale20.674,42491,4444,174,637Jan 04 06:26 PM
BRYCE RICHARD PAULSEE REMARKSJan 03Sale20.671,21025,01131,333Jan 04 05:08 PM
EYLER CHARLES RSEE REMARKSJan 03Sale20.671,21025,01132,757Jan 04 05:16 PM
EYLER CHARLES RSEE REMARKSDec 03Sale22.771,23928,21233,967Dec 04 04:59 PM
AUERBACH ALAN HPRESIDENT AND CEOJul 20Sale52.0012,520651,0204,179,061Jul 24 05:00 PM
EYLER CHARLES RSEE REMARKSJul 20Sale51.9561031,69035,206Jul 24 05:07 PM
BRYCE RICHARD PAULSEE REMARKSJul 20Sale51.951,83695,38132,543Jul 24 05:03 PM
Lo StevenChief Commercial OfficerJul 20Sale51.851,83995,36023,523Jul 24 05:10 PM
EYLER CHARLES RSEE REMARKSJun 01Sale53.001,21164,18335,816Jun 04 05:08 PM